TP53(p.R158L) Point Mutation in A-549 Cell Line
The TP53(p.R158L) Point Mutation in A-549 Cell Line is based on the newly developed Bingo™ platform, which utilizes an optimized and upgraded version of the Prime Editing (PE) gene point mutation system-currently the most efficient and safest technology available. This platform enables precise and efficient gene point mutation, resulting in a highly active and stable cell line.
Product Details
| Cat.No. | EDC90723 | Product Name | TP53(p.R158L) Point Mutation in A-549 Cell Line |
|---|---|---|---|
| Mutation Site | p.R158L, c.473G>T | Cell Line | A-549 |
| Species | Human | Gene | |
| NCBI Gene ID | Morphology | Adherent | |
| Passage Ratio | 1:5-1:4, 2days | Complete Culture Medium | F-12K + 10% FBS |
| Freezing Medium | 95% Complete medium + 5% DMSO |
STR Profile
| Loci | STR Info (Sample Cell) Sample Cell Line: A-549 | STR Info (Cell bank) Cell Line: A-549 | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| Amelogenin | X | Y | X | Y |
| CSF1PO | 10 | 12 | 10 | 12 |
| D2S1338 | 24 | 24 | ||
| D3S1358 | 16 | 16 | ||
| D5S818 | 11 | 11 | ||
| D7S820 | 8 | 11 | 8 | 11 |
| D8S1179 | 13 | 14 | 13 | 14 |
| D13S317 | 11 | 11 | ||
| D16S539 | 11 | 12 | 11 | 12 |
| D18S51 | 14 | 17 | 14 | 17 |
| D19S433 | 13 | 13 | ||
| D21S11 | 29 | 29 | ||
| FGA | 23 | 23 | ||
| Penta D | 9 | 9 | ||
| Penta E | 7 | 11 | 7 | 11 |
| TH01 | 8 | 9.3 | 8 | 9.3 |
| TPOX | 8 | 11 | 8 | 11 |
| vWA | 14 | 14 | ||
| D6S1043 | 11 | 13 | ||
| D12S391 | 18 | 18 | ||
| D2S441 | 10 | 13 | 10 | 13 |
Conclusion: The STR identification of this cell is correct.